Mark C. McKenna

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Louise Kooij by Power of Attorney from Mark C. McKenna
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark C. McKenna:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apogee Therapeutics, Inc. Director Common Stock 20,000 $997,000 $49.85 12 Dec 2024 Direct
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 10,360 $363,586 $35.10 07 Jan 2026 Direct
BridgeBio Oncology Therapeutics, Inc. Former Director Common Stock 30,000 $321,519 $10.72 11 Aug 2025 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 29 May 2025 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 15,300 07 Jan 2026 Direct
Apogee Therapeutics, Inc. Director Stock Option (Right to Buy) 14,461 17 Jun 2025 Direct
BridgeBio Oncology Therapeutics, Inc. Former Director Class B ordinary shares 0 11 Aug 2025 Direct
Prometheus Biosciences, Inc. Chairman, President and CEO, Director Common Stock 0 $108.42 16 Jun 2023 Direct
Prometheus Biosciences, Inc. Chairman, President and CEO, Director Stock Option (right to buy) 0 16 Jun 2023 Direct

Insider Reports Filed by Mark C. McKenna

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NAMS NewAmsterdam Pharma Co N.V. 07 Jan 2026 2 $0 4 Director 09 Jan 2026, 19:33
HLXB BridgeBio Oncology Therapeutics, Inc. 11 Aug 2025 2 $0 4 Former Director 11 Aug 2025, 17:01
APGE Apogee Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 20:04
SYRE Spyre Therapeutics, Inc. 29 May 2025 1 $0 4 Director 02 Jun 2025, 16:36
NAMS NewAmsterdam Pharma Co N.V. 06 Jan 2025 2 $0 4 Director 08 Jan 2025, 18:08
APGE Apogee Therapeutics, Inc. 12 Dec 2024 2 +$990,775 4 Director 16 Dec 2024, 06:00
NAMS NewAmsterdam Pharma Co N.V. 17 Jul 2024 1 $0 4 Director 19 Jul 2024, 16:31
NAMS NewAmsterdam Pharma Co N.V. 16 Jul 2024 0 $0 3 Director 19 Jul 2024, 16:30
PCSC Perceptive Capital Solutions Corp 11 Jun 2024 0 $0 3 Director 11 Jun 2024, 18:00
APGE Apogee Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 20:05
HLXB Helix Acquisition Corp. II 08 Feb 2024 0 $0 3 Director 08 Feb 2024, 21:59
SYRE Spyre Therapeutics, Inc. 01 Feb 2024 1 $0 4 Director 05 Feb 2024, 17:29
SYRE Spyre Therapeutics, Inc. 01 Feb 2024 0 $0 3 Director 05 Feb 2024, 17:25
APGE Apogee Therapeutics, Inc. 17 Aug 2023 2 $0 4 Director 21 Aug 2023, 17:06
APGE Apogee Therapeutics, Inc. 17 Aug 2023 0 $0 3 Director 21 Aug 2023, 17:05
/report/000089924323015760-mckenna-mark-c-2023-06-16 Prometheus Biosciences, Inc. 16 Jun 2023 9 $0 4 Chairman, President and CEO, Director 16 Jun 2023, 16:00
/report/000120919123034050-mckenna-mark-c-2023-06-02 Prometheus Biosciences, Inc. 02 Jun 2023 4 +$355,336 4 Chairman, President & CEO, Director 02 Jun 2023, 19:13
/report/000120919123019948-mckenna-mark-c-2023-03-15 Prometheus Biosciences, Inc. 15 Mar 2023 3 -$2,831,000 4 Chairman, President & CEO, Director 17 Mar 2023, 21:02
/report/000120919123016105-mckenna-mark-c-2023-03-01 Prometheus Biosciences, Inc. 01 Mar 2023 6 -$1,374,679 4 Chairman, President & CEO, Director 03 Mar 2023, 20:30
/report/000120919123010972-mckenna-mark-c-2023-02-15 Prometheus Biosciences, Inc. 15 Feb 2023 9 -$7,478,002 4 Chairman, President & CEO, Director 17 Feb 2023, 20:31
/report/000120919123004136-mckenna-mark-c-2023-01-17 Prometheus Biosciences, Inc. 17 Jan 2023 3 -$2,902,250 4 Chairman, President & CEO, Director 19 Jan 2023, 19:39
/report/000120919122061088-mckenna-mark-c-2022-12-09 Prometheus Biosciences, Inc. 09 Dec 2022 2 $0 4 Chairman, President & CEO, Director 13 Dec 2022, 19:32
/report/000120919122031163-mckenna-mark-c-2022-05-20 Prometheus Biosciences, Inc. 20 May 2022 1 $0 4 Chairman, President & CEO, Director 20 May 2022, 19:11
/report/000120919121067992-mckenna-mark-c-2021-12-01 Prometheus Biosciences, Inc. 01 Dec 2021 2 +$44,660 4 Chairman, President & CEO, Director 03 Dec 2021, 18:02
/report/000120919121064933-mckenna-mark-c-2021-11-14 Prometheus Biosciences, Inc. 14 Nov 2021 1 $0 4 Chairman, President & CEO, Director 16 Nov 2021, 20:03